5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile: A Deep Dive
Historical Development
Chemists started tinkering with pyrazolo[3,4-b]pyridine frameworks decades ago, always hunting for the next big advance in medicinal chemistry. The addition of fluorine atoms to these molecules didn't happen on a whim; researchers sought to enhance biological stability and activity. The drive to explore pyridine-fused heterocycles picked up in the eighties, with teams combing through possible substitutions, chasing leads for antiviral and anticancer agents. The journey of 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile emerges from that backdrop—a response to the real-world push for compounds that could outperform existing therapies and challenge tough diseases.
Product Overview
At a glance, this compound draws attention with its dual-fluorinated benzyl side chain married to a fused pyrazolo-pyridine core. Those two fluorine atoms play more than a cosmetic role. They modify the electron distribution across the molecule, which impacts how it behaves not just on the laboratory bench but also in complicated biological systems. The presence of the carbonitrile group ramps up its synthetic potential, opening avenues for further modification and expanded utility both in research and, prospectively, in therapy development.
Physical & Chemical Properties
Solid at room temperature, most batches show off a white to off-white crystalline appearance. The melting point hovers between 176°C and 184°C based on purity and batch variation, so controlling crystallization and purification techniques makes a tangible difference for those preparing research-grade samples. The molecule delivers a moderate polarity, influenced by the nitrile and the heterocyclic ring, leading to decent solubility in DMSO and DMF, but it often resists dissolving in water without special treatment. Its logP sits close to 3.1, pointing towards a delicate balance between water and lipid solubility—an important marker for molecular candidates aiming for biological systems. Chemically, it resists base and mild acid, but strong oxidants can trigger decomposition.
Technical Specifications & Labeling
Most suppliers offer the material at purity above 98%, with HPLC spectra available on request. Labels or data sheets list the product's IUPAC name along with trusted synonyms to avoid ordering confusion, especially during regulatory filings. Storage guidance sticks to cool, dry spaces away from direct light, often with a note about keeping containers tightly sealed to defend against hydrolysis over time. Researchers need clear expiration dating and batch-specific spectral data to confirm identity and purity before putting this material into critical experiments.
Preparation Method
The synthesis runs through a multi-step process. Labs usually kick things off starting with 2-fluorobenzyl bromide, which then undergoes a nucleophilic aromatic substitution with a pre-formed pyrazolopyridine core. The carbonitrile group often comes from cyanoacetamide precursors introduced early in the pathway, giving a handle for final modifications. Reaction times depend on subtle tuning—solvent choice, temperature, and the order of reagent addition can all adjust yields upward. Purification follows with chromatography or recrystallization, depending on available infrastructure. Good yield depends on careful control of moisture, since the intermediates can hydrolyze in humid conditions more readily than most suspect.
Chemical Reactions & Modifications
A big advantage of this molecule is the reactive nitrile and the two fluorine atoms, which unlock new derivatives for researchers willing to push boundaries. The benzyl group accepts further substitution, so medicinal chemists sometimes add substituents to tune receptor interaction. Reduction or hydrolysis of the nitrile yields corresponding amides or amines, creating new scaffolds for library expansion efforts. The core ring structure puts up solid resistance to ring cleavage, giving a platform for further modification without losing the basic biological activity. This kind of backbone stability often pays off in metabolic and pharmacokinetic studies.
Synonyms & Product Names
Catalogs and research papers have referred to this compound as 5-Fluoro-1-(2-fluorobenzyl)pyrazolo[3,4-b]pyridine-3-carbonitrile, FFBPPCN, and even as pyrazolopyridine carbonitrile, 2-fluorobenzyl fluorinated. These names mirror the ever-changing cataloging practices in chemistry, so cross-referencing CAS numbers and checking structural diagrams becomes essential. Labs value clarity here—naming slip-ups lead to lost time and wasted resources, and more than a few researchers have ordered the wrong compound by relying solely on abbreviations or partial names.
Safety & Operational Standards
Safety matters long before a lab coat goes on. Material Safety Data Sheets (MSDS) mark this compound as irritating to skin, eyes, and mucous membranes, so gloves, goggles, and fume hoods come standard with every synthesis or handling session. Proper labeling prevents mix-ups, particularly in busy shared spaces. Waste from synthesis processes calls for solvent-specific disposal—incineration for organic waste, working through approved hazardous waste programs for any remaining solids. Air handling systems and spill cleanup kits should always sit within easy reach, since small spills can create persistent odors or lingering contamination if not handled right away.
Application Area
Pharmaceutical research grabs the spotlight here. The molecule’s structure supports strong interactions at various biological sites, and teams have used analogs as kinase inhibitors and in anti-proliferative screens targeting cancer cell lines. Analytical chemists lean on it as a structural probe during method development for LC-MS/MS due to the unique fragmentation pattern offered up by the double-fluorinated scaffold. While not a mainstay in agriculture or materials chemistry, the spectrum of possible modifications points to potential crossover uses, such as in fluorescent probe development or as starting material for more complex heterocyclic drugs.
Research & Development
Early-phase studies suggest structural analogs suppress cancer cell growth in vitro and occasionally tweak metabolic pathways that traditional small molecules can't touch. Researchers continue to unravel structure-activity relationships, hoping to maximize potency while steering clear of off-target effects. Direct-to-animal testing remains rare, but a few groups have started in vivo screens to probe pharmacokinetics, metabolic stability, and bioavailability. Patent filings show slow and steady interest, mostly by academic spinouts with long-term plans for intellectual property protection of useful derivatives.
Toxicity Research
Available data points towards manageable toxicity, at least at cell and organoid levels; cytotoxicity readings track closely with established drugs that act on cell signaling, but higher dosages produce mild mitochondrial disruption. Rodent studies lag behind, in part due to the field’s hesitancy to push new fluorinated species without clear off-target and environmental breakdown profiles. Long-term accumulation hasn’t emerged as a red flag in basic cell cultures, yet questions about breakdown products and persistence in the environment keep regulatory teams cautious.
Future Prospects
There's real optimism about where this structure could go. Medicinal chemists eye new derivatives as possible answers to stubborn resistance in cancer therapy, especially in tumors expressing kinase mutations. Advances in synthetic methodology might simplify access, cut costs, and accelerate preclinical evaluations. Rising demand for tunable scaffolds in chemical biology tools also points toward broader adoption in screening libraries and as platform molecules. As the regulatory landscape around fluorinated organics sharpens, research will need to show clear degradation pathways, ensuring that next-generation analogs leave no toxic legacy in the environment.
Tapping Into the Heart of Research Chemistry
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile doesn't roll off the tongue and it's even harder to remember in a lineup of complicated science terms. Yet, this molecule has turned more than a few heads in research labs. Its main role plays out behind the scenes of drug development, where chemists explore whole families of compounds in the hunt for new medicines. This chemical belongs to a group known as pyrazolo[3,4-b]pyridines, famous for their ability to lock into certain receptor sites in the brain and body. Chemistry doesn’t just happen in a vacuum—here, it gives a real shot at treating conditions that beat traditional treatments.
Why Scientists Dig So Deep on Molecules Like This
Labs look for special molecules that might someday help people manage tough conditions, especially neurological or psychiatric ones. Researchers tailor molecules like 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile to fit special pockets on proteins called receptors. In this case, the buzz often points toward cannabinoid receptors. These show up in parts of the body linked to pain, mood, and inflammation. By tweaking bits of these molecules, scientists hope to make medicines that hit the bullseye on symptoms, without tripping up other parts of the body.
Behind the Calls for Safety
Safety always comes first with lab work, especially once word gets out about molecules touching the endocannabinoid system. A few years back, some of these designer drugs slipped out of the lab and into the wrong hands. Synthetic cannabinoids have caused health emergencies. Shortcuts in production, lack of testing, and reckless dosing all turned what looked promising into a risk. The lesson seems clear—what happens in a beaker doesn’t always belong in smoke shops or on street corners. That’s why real research moves slow, checking effects step by step and making sure every stone gets turned over along the way.
Solutions for Safer Science and Public Health
Putting new chemicals to the test in a clinical setting soaks up the bulk of drug development budgets. It pays to collaborate, drawing clear lines between academic discovery and commercial shortcuts. Laws should back up public health, blocking these risky compounds from hitting the streets before anyone knows what they really do. Science can’t move forward without strong ethics. Researchers who share accurate results, peer-reviewed, help keep progress honest. Education helps, too. If regular folks know why some new compounds get flagged, it stops fake buzz before it starts.
Looking Ahead
The world of research chemicals changes fast, and so do the headlines that follow. Each discovery could point to relief for millions who struggle with pain or mood disorders that old pills fail to touch. 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile serves as one piece in a much bigger puzzle. While the compound itself sits in the research phase, its story offers a warning and a promise—big breakthroughs only mean something when safety, transparency, and purpose stay at the forefront.
Looking Beyond the Chemistry
Long chemical names often stir up a mix of confusion and curiosity. 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile belongs to a class of lab-synthesized compounds that exist well outside the average person's medicine cabinet. Digging into the science, chemicals like this sometimes show up in early-phase pharmaceutical research, mostly behind closed lab doors, rather than on a pharmacy shelf.
No Green Light From Health Authorities
No major drug regulatory body—including the FDA, EMA, or Japan’s PMDA—has approved this compound as safe for human use. There’s a reason for that. Every drug or food additive claiming a benefit or “new” effect gets run through a gantlet of safety and efficacy trials. Researchers look for toxicity, side effects, and ways the body breaks down these compounds. Right now, there’s no record of any such official testing for this molecule. That means no established dose, no safety threshold, and no long-term data.
Research Chemicals, Real Risks
Some chemists list this kind of compound as a “research chemical.” That’s science jargon for “someone made this in a lab, but no one knows what it does in a living body.” Online, you’ll find foreign websites selling powders for “research use only,” but there’s little stopping people from taking risks on themselves. Reports from hospital emergency rooms show side effects from similar synthetic compounds—nausea, panic, seizures, and kidney problems. These symptoms sometimes arise because nobody mapped out what the substance does in the brain, the liver, or the heart.
Human Health Carries Unknowns
Trying substances with no safety record can lead to a bad outcome, and not just one that sends a person to the emergency room. Research chemicals can trigger sudden heart rhythm changes, liver damage, or neurological symptoms. Without published data, doctors get left guessing about treatment if someone shows up sick. In my experience, even smart users misjudge risk when faced with a compound outside mainstream science.
Accountability and the Path Forward
Real safety comes from transparent testing. Bodies like the FDA demand animal studies, human trials, and published results before giving a green light. Bypassing that process—out of curiosity or impulse—dumps all the risk on individuals and emergency care providers. If curiosity around new compounds keeps growing, countries should tighten e-commerce controls and boost public health education on the dangers of unsupervised chemical use.
Think Twice, Ask Questions
No lab coat or online vendor can give the full story. If there’s no published safety data, the safest answer stays simple: Don’t consume it. Talk to medical professionals, seek out published studies, and treat untested substances with caution. The human body only gets one shot at health, and nobody wants to become the data point for a compound’s hidden dangers.
Knowing the Substance
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile pops up in discussions about drug development and research. It belongs to a group of synthetic compounds sharing similarities with substances used for experimental medicines. As labs continue to explore its properties, there’s growing curiosity about what this molecule might do once inside the human body.
Where Real Risks Begin
I’ve seen the rush to bring cutting-edge treatments to the table, but the excitement sometimes overshadows caution. With compounds like this, the risks often start quietly. In research settings, similar molecules have caused nausea, headaches, fatigue, and even confusion. These are more than inconveniences—they’re signals. The body pushes back against something new and unfamiliar, and those signals are worth heeding before anything moves out of the research stage.
Digging Into Systemic Effects
Scientists running early studies noticed some pyrazolopyridine derivatives interact with enzymes in the liver. That’s not a surprise. The liver’s job is to break down chemicals. Stressing it with unknown compounds can lead to inflammation or damage, reflected in lab markers like elevated liver enzymes. I’ve seen cases where these changes reveal themselves as jaundice, dark urine, or just a sudden drop in energy. Sometimes, this goes away when the compound leaves the system; sometimes, the damage sticks around. Lab animals often tell a similar story before human trials ever start, offering a necessary warning flag.
Psychological and Neurological Consequences
I remember a clinical team grappling with restlessness and disturbed sleep in volunteers exposed to related quinoline structures. These aren’t problems anyone should ignore. Some affected people spoke of anxiety, flashes of paranoia, and in rare cases, hallucinations. The brain’s balance gets disrupted, and nobody benefits from treating the mind as collateral damage. Researchers must track neurological and psychological outcomes, report adverse events, and not just chase the rush of a potential breakthrough.
Allergies and Immune Response
The immune system doesn’t show mercy to unfamiliar chemicals. Some test subjects developed rashes or hives after contact with new compounds in this chemical family. Swelling around the face, lips, or throat signals a dangerous reaction—anaphylaxis. Emergency care deals with the immediate threat, but these events must shape the judgment of ethics committees long before full-scale trials.
Long-Term Unknowns
Many early warnings don’t surface until a compound stays in the system. In long-term animal studies, toxins sometimes build up. Kidney function can drop, cells in organs may become abnormal, or the immune system might stay on high alert. These outcomes demand follow-up in post-trial surveillance. I’ve lost count of the times a promising molecule turned risky after real-world exposure.
Solutions and Best Practices
Before trialing experimental drugs in people, researchers need solid data from lab tests and animal studies. Transparency saves lives. Regulators and ethics boards rely on detailed adverse event logs, tissue studies, and long-term animal results. Practicing medicine means balancing hope with hard evidence, not sidestepping known or possible harms. Clear patient information, close monitoring, and robust reporting standards stand as safeguards against turning curiosity into tragedy.
Why Storage Conditions Deserve Attention
Not every chemical on the lab shelf demands the same handling, but 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile brings extra responsibility. The intricate name points to a modern class of research agents, usually tied to chemical biology or pharmaceuticals. Researchers who work with advanced molecules like this already juggle tight protocols, but safe storage forms the base for any serious work and for protecting users and the integrity of results.
What Makes Proper Storage So Critical?
At home, people keep milk in the fridge for a reason—it stays fresh and safe longer. In the lab, chemicals need similar respect. Some compounds, especially those with sensitive cyano or fluorine groups, react in unexpected ways when exposed to heat, light, or moisture. Exposure can skew results, break down the molecule, or worse, create hazardous byproducts. This isn’t just a matter of lab neatness—degradation can hurt people’s health and force costly research setbacks.
Specific Hazards With Fluorinated Compounds
Fluorine gives molecules useful properties, but it also brings extra caution. Both fluorine and nitrile groups have made headlines in industrial and pharmaceutical circles for their reactivity under heat or light. Unwanted reactions can release toxic gas or damage equipment. Also, containers that seem airtight sometimes allow in tiny amounts of moisture or air, which over weeks or months add up to real trouble.
Best Practices From Experience
Labs that handle this class of product usually rely on air-tight, amber-colored glass bottles. The amber color blocks ultraviolet and much visible light, helping slow down any unwanted breakdown. Many researchers follow the advice on Sigma-Aldrich and other major chemical suppliers, keeping such bottles away from direct sunlight and heat sources, tucked into cabinets or temperature-stable rooms.
For maximum stability, dry storage at low temperature gets top marks. Refrigerators between two and eight degrees Celsius handle most chemicals well, but for those prone to oxidation or hydrolysis, low humidity sealed storage makes a difference. Desiccators—airtight chambers with drying agents—act as cheap insurance for expensive materials, holding off moisture that slowly eats away at purity.
In my own research days, storage mistakes had a way of getting expensive. I once watched a colleague lose an entire order of a similar fluorinated compound to a warm, bright stockroom. A week in and the sample turned brown, giving both garbage data and wasted budget. After that, we made sure to use color-coded tape and clear logs so anyone could see at a glance where sensitive or hazardous compounds belonged.
Solid Inventory Practices Help Everyone
Smart storage includes careful labeling and record-keeping. Any container should show the contents, date received, and who’s responsible. Some labs print condition requirements on every label, nudging the busy or forgetful. Regular reviews of stocks help spot any changes—odd colors, clumping, or suspicious pressure—before problems spread. Simple steps like those save both time and headaches later.
Pushing for Better Safety and Consistency
Consistency across the science community keeps both products and people safe. Many universities and industrial groups share safety alerts or incident reviews so small errors don’t get repeated elsewhere. The right policies, plus affordable equipment, set everyone up for fewer accidents and higher reliability, whether working with novel research chemicals or widely used reagents.
For anyone storing 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile, clear communication, proven protocols, and a dash of real-world experience go a long way. Skimping on any of those often costs more than the price of one small bottle.
The Substance at the Center of New Interest
People with backgrounds in chemistry or pharmacology may have noticed the rising conversation around 5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile. Academic labs, online vendors, and law enforcement share an uneasy relationship with synthetic substances, especially ones that feel like they exist in legal gray zones. This compound is mostly discussed in the same circles as designer drugs and unregulated research chemicals, which can make for tricky territory.
Laws That Aren’t Always Clear
Laws in the United States treat these chemicals differently depending on the state or federal perspective. Most people outside legal or medical fields don’t follow daily changes in designer drug bans. The federal Controlled Substances Act covers drugs that Congress or the DEA specifically names or defines. This compound hasn’t been scheduled at the federal level by name. But the law includes an Analog Act, which means substances that are “substantially similar” to scheduled drugs in chemical structure or effect can also land someone in legal trouble. Local law enforcement and courts often decide what “substantially similar” means on a case-by-case basis. Some states have taken preemptive action—banning wide classes of pyrazolopyridine or similar research chemicals outright. That means what's legal in one city may bring big trouble just a few miles down the highway.
What I’ve Learned From the Community
People often find these compounds through online research forums or synthetic chemistry supply stores. Years spent following changes in research chemical law and policy have shown that most buyers come from scientific backgrounds or from curious corners of the internet. Some pursue legitimate laboratory research, hoping to study properties that may help scientists explore new medications. Others want to experiment personally with unscheduled substances.
I’ve seen posts, emails, and questions from people surprised when a legal-sounding chemical earns a knock on the door from the postal inspector or gets a shipment seized at customs. Law enforcement agencies keep close tabs on the postal service and international shipping, especially since some research chemicals can act a lot like banned drugs. I’ve read court filings in cases where prosecutors argued not just possession, but intent to distribute, based on the quantity involved.
Recognizing the Risks
The bottom line is that legal gray areas create big risks for researchers, chemists, or curious individuals. Getting comfortable because a compound isn’t scheduled can backfire. Most users don’t realize prosecutors could push for criminal charges anyway, using evidence drawn from chemical similarity, packaging, or even hazard to public health. The cost of a criminal defense, career damage, or permanent record rarely gets factored into conversations until it’s too late. I’ve talked with people who lost jobs or graduate school opportunities over substances that they never intended to use in any way that would harm themselves or others. Legal ambiguity doesn’t prevent consequences when prosecutors and regulators step in.
Working Toward Practical Solutions
Clearer regulation and education could help people stay out of unintentional legal danger. Scientific organizations and universities can create reliable guidelines about chemical procurement and possession. Vendors have a chance to support buyers with plain-language updates on local laws before they ship orders. Public health and safety agencies might provide open-access information that details the known risks and shifting legal landscape for compounds like this one. Curiosity and research thrive best in a climate where people know the rules—and the risks—upfront. Until better communication arrives, anyone interested in these compounds should talk to a legal expert, consult local laws, and never assume lab-sounding names guarantee safety or legality.
![5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile](/static/addc9509-2be4-4959-982b-d09ecb4f6812/images/2d/5-fluoro-1-2-fluorobenzyl-1h-pyrazolo-3-4-b-pyridine-3-carbonitrile.png)
![5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile](/static/addc9509-2be4-4959-982b-d09ecb4f6812/images/3d/5-fluoro-1-2-fluorobenzyl-1h-pyrazolo-3-4-b-pyridine-3-carbonitrile.gif)
